The South Korea peptic ulcer market size stood at around USD 721.7 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.
Peptic ulcers are open sores that develop on the inside lining of stomach and the upper portion of small intestine. The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen sodium. Stress and spicy foods do not cause peptic ulcers. However, they can make the symptoms worse. Most common symptoms are burning stomach pain, feeling of fullness, bloating, or belching, intolerance to fatty foods, heartburn, and nausea. Peptic ulcer is one of the most commonly encountered gastroenterological diseases in Korea.
The major driving factors for peptic ulcers drug market are increase in the stress and drug induced ulcers. Growing rate of infection by H. Pylori, changes in food, rise in cancer, tobacco and alcohol use are propelling factors for this market. Restraining factors of this market are expiry of patent, H. Pylori resistance and extreme market fragmentation.